Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.
about
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesCharacterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients.Effect of Eugenol against Streptococcus agalactiae and Synergistic Interaction with Biologically Produced Silver NanoparticlesMolecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.Salvage Procedures for Management of Prosthetic Joint Infection After Hip and Knee Replacements.High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland.High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.Streptococcus agalactiae infection in cancer patients: a five-year study.Asymptomatic group B streptococcal bacteriuria among pregnant women in Saudi Arabia.Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility.
P2860
Q28075884-134715DA-2D04-4928-BACE-A79E5AF1DBB4Q33703629-078B5DF5-8E32-43CC-A58B-77E35A57C757Q34037817-93BBC7DF-FEF3-4710-8440-7CA656D3FECEQ35035805-0B3AC3AD-7680-4C71-986E-BA4F8FF947C5Q35169242-C6D94A91-B2ED-458A-BE8C-4CA9E8294F39Q35512019-A74BFD96-7EBA-4BC6-A1B1-B45ADE2B039BQ37363399-8CA2BB94-184B-421E-93D3-CE36429D87FBQ37428706-0C0C45B7-7E16-4435-AC3C-41941EB56645Q37580818-733659E0-44FA-4E62-B85D-53FE85EDE065Q39528009-20FB44D5-4CE2-4D8A-A55C-0006A0EE7B2FQ40673578-35E5D525-5755-4602-A1C2-79F62C1F3290Q40743043-8E1FD063-BB6B-4C87-9A74-2AE3C1BBF277Q40749371-CDEB6679-6455-4B76-BEED-950ED749747DQ40934042-CB483824-5336-41A5-AABC-FF98B9514AF5Q43125901-C54468A1-EE35-4FDF-B57B-39205959A54CQ46247272-6CFCD520-EAF0-4788-B203-FDEEA61E9F1DQ47546256-87664397-8AC4-4822-8C2B-3028094FAB45Q54426775-E7CCA182-EBF8-45C2-953D-C375738AF445
P2860
Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel mutations in a patient i ...... term oral suppressive therapy.
@ast
Novel mutations in a patient i ...... term oral suppressive therapy.
@en
type
label
Novel mutations in a patient i ...... term oral suppressive therapy.
@ast
Novel mutations in a patient i ...... term oral suppressive therapy.
@en
prefLabel
Novel mutations in a patient i ...... term oral suppressive therapy.
@ast
Novel mutations in a patient i ...... term oral suppressive therapy.
@en
P2093
P2860
P356
P1476
Novel mutations in a patient i ...... -term oral suppressive therapy
@en
P2093
Christie Vermeiren
Dea Shahinas
Donald E Low
Dylan R Pillai
Gurdip Singh Tamber
Jean Longtin
Kevin Katz
P2860
P304
P356
10.1128/AAC.01243-10
P407
P577
2011-03-07T00:00:00Z